PATENT CLAIM ANALYSIS

Application Number: 15906438
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["424", "426000"]

Abstract:
Disclosed herein are methods, processes, compositions, and kits for generating bone graft materials for use at a site of bone defect that utilizes a composition which contains liposomal Wnt polypeptide, such as liposomal Wnt3a polypeptide, liposomal Wnt5a polypeptide, or liposomal Wnt10b polypeptide. Also disclosed herein are methods, processes, compositions, and kits for enhancing mammalian bone marrow cells that utilizes a composition which contains liposomal Wnt polypeptide, such as liposomal Wnt3a polypeptide, liposomal Wnt5a polypeptide, or liposomal Wnt10b polypeptide.

Claim (Index 17):
The method of  claim 15 , wherein the Wnt3a polypeptides comprise at least about 30%, about 40%, about 50%, about 60%, about 70%, about 80%, about 90%, or about 95% sequence identity to the amino acid sequence as set forth in SEQ ID NO: 1 or comprise the amino acid sequence at set forth in SEQ ID NO: 1.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 88.0
- Lexical Diversity: 2.2439
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14910616', '15868395', '15063317', '14333220', '14337718']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7594559544296668
- 35 USC 102 Novelty (BERT): 0.6575558317395632
- Combined Prediction Score: 0.7492659421606566
- Mean Citation Score: 459.294376
- Max Citation Score: 665.31616
- Similarity Product: 589.7464650490951

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test